Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
9.35
-0.94 (-9.14%)
At close: Jun 5, 2026, 4:00 PM EDT
9.67
+0.32 (3.46%)
After-hours: Jun 5, 2026, 7:58 PM EDT

Alpha Tau Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Alpha Tau Medical stock has a consensus rating of "Buy" and an average price target of $14.2. The average 1-year stock price forecast is 51.87% higher than the current stock price, while the lowest is $8.00 (-14.44%) and the highest is $17 (+81.82%).

Price Target: $14.2 (+51.87%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$8.00$14.2$15$17
Change-14.44%+51.87%+60.43%+81.82%

Analyst Ratings

The average analyst rating for Alpha Tau Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy333333
Buy110011
Hold001111
Sell000000
Strong Sell000000
Total444455

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$15$17
BuyMaintains$15$17+81.82%Jun 4, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$15
BuyReiterates$15+60.43%Jun 2, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$5$8
HoldReiterates$5$8-14.44%May 19, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Reiterates
$14
BuyReiterates$14+49.73%May 12, 2026
Citi
Citi
Buy
Reiterates
$7$9
BuyReiterates$7$9-3.74%Mar 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
850.50K
Revenue Next Year
12.39M
from 850.50K
Increased by 1,356.49%
EPS This Year
-0.65
from -0.53
EPS Next Year
-0.50
from -0.65
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----850.50K
Operating Income
-13.79M-32.14M-35.68M-36.04M-42.29M-51.91M
EPS
-----0.53-0.65
Free Cash Flow
-7.53M-14.62M-19.40M-12.97M-19.70M-95.00M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.7M
Avg850,500
Lown/a

Revenue Growth

Revenue Growth20272028
High
3,358.0%
Avg
1,356.5%
Low
-100.0%

EPS Forecast

EPS202620272028
High-
Avg-0.65
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-